Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion type Assertion NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_head.
- NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion description "[Particularly in the subgroup of patients without diffuse-type histology, HER2-positive gastric cancer had a worse TTP than those with HER2-negative gastric cancer (p=0.024).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_provenance.
- NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion evidence source_evidence_literature NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_provenance.
- NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion SIO_000772 22493400 NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_provenance.
- NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion wasDerivedFrom befree-20140225 NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_provenance.
- NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_assertion wasGeneratedBy ECO_0000203 NP600785.RAXIlSDV1JuFn_1fxgLT4Jrr2k3Nl1dEypS9ENaDdp55A130_provenance.